# OnCo record breakbio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/breakbio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "breakbio" ;
  schema:name "BreakBio"@en ;
  schema:alternateName "BreakBio Corp"@en ;
  schema:description "BreakBio makes a cancer vaccine designed for one person at a time: it reads the genes and proteins of a patient's own tumour, picks targets, and manufactures peptides meant to train the immune system against them. Its first trials, in triple-negative breast cancer and glioblastoma, were due to start in 2026."@en ;
  schema:url <https://onco.cc/companies/breakbio/>, <https://breakbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://breakbio.com/>, <https://clinicaltrials.gov/study/NCT07762716> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/neoantigen-mrna-vaccine/> ;
  onco:trials <https://onco.cc/trials/nct07762703/> .